Participations Besançon Overview
- Investor Type
- Venture Capital
- Investments
- 3
- Portfolio
- 2
Participations Besançon General Information
Contact Information
Primary Investor Type
Venture Capital
Participations Besançon Investments (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Pherecydes Pharma | 16-Jan-2018 | Later Stage VC | 000.00 | Biotechnology | Generating Revenue | |
| 000000000 00000000 | 27-May-2016 | 00000 00000 | 00.00 | Drug Discovery | Clinical Trials - Phase 1 | 000000 00000ç00 |
| 000000000 00000000 | 13-Jan-2015 | 0000 00000 | 00.000 | Drug Discovery | Clinical Trials - Phase 1 | 000000 00000ç00 |
Participations Besançon Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialParticipations Besançon Team (1)
| Name | Title | Deals | Funds | Boards | Office |
|---|---|---|---|---|---|
| Pierre Besançon | Managing Partner | 0 |
Participations Besançon Co-Investors (9)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| GO Capital (France) | 2 | 0 |
|
|
|
| ACE Management (Paris) | 0 | 0 |
|
|
|
| Auriga Partners (Paris) | 0 | 0 |
|
|
|
| Elaia Partners | 0 | 0 |
|
|
|
| Omnes Capital | 0 | 0 |
|
|